| Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level J Chen, YR Kao, D Sun, TI Todorova, D Reynolds, SR Narayanagari, ... Nature medicine 25 (1), 103-110, 2019 | 223 | 2019 |
| Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemia LA Carvajal, DB Neriah, A Senecal, L Benard, V Thiruthuvanathan, ... Science translational medicine 10 (436), eaao3003, 2018 | 214 | 2018 |
| New IDH1 mutant inhibitors for treatment of acute myeloid leukemia UC Okoye-Okafor, B Bartholdy, J Cartier, EN Gao, B Pietrak, AR Rendina, ... Nature chemical biology 11 (11), 878-886, 2015 | 190 | 2015 |
| Eltrombopag inhibits the proliferation of leukemia cells via reduction of intracellular iron and induction of differentiation M Roth, B Will, G Simkin, S Narayanagari, L Barreyro, B Bartholdy, ... Blood, The Journal of the American Society of Hematology 120 (2), 386-394, 2012 | 167 | 2012 |
| Direct activation of BAX by BTSA1 overcomes apoptosis resistance in acute myeloid leukemia DE Reyna, TP Garner, A Lopez, F Kopp, GS Choudhary, A Sridharan, ... Cancer cell 32 (4), 490-505. e10, 2017 | 153 | 2017 |
| Minimal PU. 1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia B Will, TO Vogler, S Narayanagari, B Bartholdy, TI Todorova, ... Nature medicine 21 (10), 1172-1181, 2015 | 126 | 2015 |
| Pharmacological inhibition of the transcription factor PU. 1 in leukemia I Antony-Debré, A Paul, J Leite, K Mitchell, HM Kim, LA Carvajal, ... The Journal of clinical investigation 127 (12), 4297-4313, 2017 | 109 | 2017 |
| A small-molecule allosteric inhibitor of BAX protects against doxorubicin-induced cardiomyopathy D Amgalan, TP Garner, R Pekson, XF Jia, M Yanamandala, V Paulino, ... Nature cancer 1 (3), 315-328, 2020 | 87 | 2020 |
| IL1RAP potentiates multiple oncogenic signaling pathways in AML K Mitchell, L Barreyro, TI Todorova, SJ Taylor, I Antony-Debré, ... Journal of Experimental Medicine 215 (6), 1709-1727, 2018 | 80 | 2018 |
| Thrombopoietin receptor–independent stimulation of hematopoietic stem cells by eltrombopag YR Kao, J Chen, SR Narayanagari, TI Todorova, MM Aivalioti, M Ferreira, ... Science translational medicine 10 (458), eaas9563, 2018 | 64 | 2018 |
| MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanism K Ueda, R Kumari, E Schwenger, JC Wheat, O Bohorquez, ... Cancer cell 39 (4), 529-547. e7, 2021 | 23 | 2021 |
| A myeloid tumor suppressor role for NOL3 RF Stanley, RT Piszczatowski, B Bartholdy, K Mitchell, WM McKimpson, ... Journal of Experimental Medicine 214 (3), 753-771, 2017 | 9 | 2017 |
